Literature DB >> 7520238

Thiabendazole is an inducer of cytochrome P4501A1 in cultured rabbit hepatocytes.

L Aix1, X Rey-Grobellet, G Larrieu, P Lesca, P Galtier.   

Abstract

The effect of TBZ (30-100 microM) was investigated on cytochromes P450 of cultured rabbit hepatocytes considered 72 h after plating. At the highest concentrations and without apparent cellular toxicity, the drug provokes a dose-dependent increase in total microsomal cytochrome P450 and a rise in EROD activity which was correlated to a specific increase in P4501A1 level. Northern blot analysis of RNA reveals an increased level of mRNA specific to P4501A1. The transcriptional activation of this isoenzyme is proposed because of the significant inhibition of the above-mentioned increases when actinomycin was added to the culture medium. Data obtained from competition experiments demonstrate that TBZ is not a ligand of Ah receptor. A down-regulation process could explain the slight decrease in both ANOH and P4502E1 level observed in hepatocytes treated with the highest dose of TBZ.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7520238     DOI: 10.1006/bbrc.1994.2098

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

Review 1.  The search for endogenous activators of the aryl hydrocarbon receptor.

Authors:  Linh P Nguyen; Christopher A Bradfield
Journal:  Chem Res Toxicol       Date:  2007-12-13       Impact factor: 3.739

2.  Omeprazole induces NAD(P)H quinone oxidoreductase 1 via aryl hydrocarbon receptor-independent mechanisms: Role of the transcription factor nuclear factor erythroid 2-related factor 2.

Authors:  Shaojie Zhang; Ananddeep Patel; Bhagavatula Moorthy; Binoy Shivanna
Journal:  Biochem Biophys Res Commun       Date:  2015-10-09       Impact factor: 3.575

3.  Establishment of a stable aryl hydrocarbon receptor-responsive HepG2 cell line.

Authors:  Hideo Satsu; Kazutaka Yoshida; Ayano Mikubo; Haru Ogiwara; Takahiro Inakuma; Makoto Shimizu
Journal:  Cytotechnology       Date:  2014-03-26       Impact factor: 2.058

Review 4.  The Aryl Hydrocarbon Receptor (AHR): A Novel Therapeutic Target for Pulmonary Diseases?

Authors:  Binoy Shivanna; Chun Chu; Bhagavatula Moorthy
Journal:  Int J Mol Sci       Date:  2022-01-28       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.